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Epsin is a ubiquitin-binding endocytic adaptor, which is highly
concentrated at clathrin-coated pits and coordinates acquisition of
bilayer curvature with coat recruitment and cargo selection. Epsin
is encoded by three distinct genes in mammals. Epsin 1 and 2 have
broad tissue distribution with high-level expression in the brain. In
contrast, epsin 3 was reported to be expressed primarily in imma-
ture keratinocytes. Here, we show that epsin 3 is selectively ex-
pressed at high levels in the stomach (including the majority of
gastric cancers), where it is concentrated in parietal cells. In these
cells, epsin 3 is enriched and colocalized with clathrin around apical
canaliculi, the sites that control acidiﬁcation of the stomach lumen
via the exo-endocytosis of vesicles containing the H/K ATPase. De-
letion of the epsin 3 gene in mice did not result in obvious patho-
logical phenotypes in either the stomach or other organs, possibly
because of overlapping functions of the other two epsins. How-
ever, levels of EHD1 and EHD2, two membrane tubulating proteins
with a role in endocytic recycling, were elevated in epsin 3 knock-
out stomachs, pointing to a functional interplay of epsin 3with EHD
proteins in the endocytic pathway of parietal cells. We suggest that
epsin 3 cooperates with other bilayer binding proteins with curva-
ture sensing/generating properties in the specialized trafﬁc and
membrane remodeling processes typical of gastric parietal cells.
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Clathrin-mediated endocytosis represents the major pathwaythat cells use for the selective internalization of plasma
membrane proteins and their extracellular ligands. Binding of
clathrin to the plasma membrane is mediated by the clathrin
adaptors (1, 2). One such adaptor is epsin, which is expressed by
three different isoforms in mammals (3–5). Epsin comprises an
epsin N-terminal homology (ENTH) domain, which directly
interacts with the bilayer and also has membrane-deforming
properties, followed by an extended, primarily unfolded tail that
contains, in sequence, binding motifs for ubiquitin, the endocytic
adaptor AP-2, clathrin, and EH domains (3, 6–10). Through
these multiple interactions, epsin is thought to coordinate the
recruitment of ubiquitinated cargo proteins with the nucleation
and growth of endocytic clathrin-coated pits.
Most studies to date have focused on epsin 1 and 2, which are
concentrated in the brain, but have broad tissue distribution (3, 10,
11). Little is known about epsin 3, except that it was reported to be
expressed, nearly exclusively, in immature keratinocytes (12). In
a survey of several tissues, we have now detected a strikingly se-
lective expression of epsin 3 in the stomach and, more speciﬁcally,
in its oxyntic region. Such region is enriched in parietal cells
(oxyntic cells): that is, the cells specialized for the acidiﬁcation of
the stomach lumen. A unique feature of these cells is a highly de-
veloped membrane-recycling machinery at their apical pole that
mediates the shuttling of the H/K ATPase between intracellular
tubulovesicular structures and the cell surface. Regulation of the
pH in the stomach lumen is critically dependent on the exo- and
endocytosis of H/K ATPase-containing vesicles. Given the endo-
cytic function of epsin, theseﬁndings raised the possibility that high-
level expression of epsin 3 in the stomach may reﬂect its selective
enrichment at apical endocytic sites in gastric parietal cells. The
massive specialization of these cells for endocytic recycling makes
them a powerful model system toward the elucidation of recycling
mechanisms in mammalian cells. Thus, we have characterized the
precise localization of epsin 3 in the stomach and we have explored
the potential signiﬁcance of this localization.
Results and Discussion
Epsin 3 Is Expressed at High Levels in the Stomach. As assayed by
Western blotting, the distribution of epsin 3 in adult mouse tissues
is highly heterogeneous. By far, the highest expression was detec-
ted in the stomach (Fig. 1 A and B). The much broader expression
of epsin 1 and 2 (Fig. 1B) (11) conﬁrmed the isoform speciﬁcity of
the anti-epsin 3 antibodies, which was further validated by the
absence of immunoreactivity in the corresponding tissues obtained
from an epsin 3 knock-out (KO) mouse (Fig. 1 A and B) (see be-
low). Further analysis of the expression of epsin 3 in different
regions of the stomach [forestomach/cardiac region, fundus, oxy-
ntic region, and pyloric region (13)] by Western blotting identiﬁed
the oxyntic region as the site of highest concentration (Fig. 1C).
Selective Enrichment of Epsin 3 in Gastric Parietal Cells. The cellular
localization of epsin 3 in the mouse stomach was examined by
immunoﬂuorescence. Low-power views of frozen sections (Fig.
2A) showed that epsin 3 was predominantly concentrated in pa-
rietal cells of the gastric glands, but no labeling was detected in
stomach sections of epsin 3 KO mice (Fig. 2B). Epsin 3 was
expressed at onlymuch lower levels inmucosal cells of the stomach
surface, and other gastric cells were epsin 3-negative (Fig. 2 A and
B). This localization was conﬁrmed by double immunoﬂuores-
cence for epsin 3 and for H/K ATPase, a speciﬁc marker of gastric
parietal cells (Fig. 2 C and D) (14).
Epsin 3 Is Localized at Clathrin-Coated Pits of Apical Canaliculi of
Parietal Cells. Gastric parietal cells have a unique structure that
reﬂects their specialized function in acid secretion. Their apical
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luminal surface, which is characterized by deep invaginations
(canaliculi), is the site where H/K ATPase pumps protons into
the gastric lumen (14). Regulation of this transport is primarily
achieved by the incorporation and removal of the H/K ATPase
into and from the membrane of the canaliculi by exo-endocy-
tosis. At rest, H/K ATPase is localized primarily in intracellular
tubulovesicles. Upon appropriate stimulation, such as in re-
sponse to histamine, it translocates to the apical membrane
leading to a dramatic enlargement of canaliculi and to in-
creased transport of H+ into the gastric lumen. This activated
state is reversed by the endocytosis of H/K ATPase-containing
apical canalicular membrane to regenerate intracellular tubu-
lovesicles (15).
Because epsin is an endocytic adaptor, we hypothesized that the
high levels of epsin 3 in parietal cells reﬂected a specialized
function in the endocytosis of apical membrane. To investigate
whether epsin 3 immunoreactivity localized at endocytic sites of
Fig. 1. Epsin 3 is highly expressed in the body region of the stomach.Western
blots of total homogenates of multiple mouse organs (A and B) and stomach
subregions (C) with anti-epsin 3 speciﬁc polyclonal (pAb) and monoclonal
(mAb) antibodies, as well as with antibodies directed against epsin 1 and 2.
Immunoblotting for GAPDH and tubulin were used as loading controls.
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Fig. 2. Localization of epsin 3 in the wall of the body of the stomach. Im-
munoﬂuorescence of thick (10 μm) (A and B) and semithin (0.5 μm) (C–F)
frozen sections. (A) Epsin 3 is selectively concentrated in parietal cells
(arrows) and also present, but at lower concentration, in the mucous-
secreting cells that line the stomach lumen (arrowheads). (B) Epsin 3 im-
munoreactivity is absent from the stomach of epsin 3 KO mice. (C–F)
Immunoﬂuorescence images showing that cells positive for epsin 3 are also
positive for H/K ATPase immunoreactivity, a speciﬁc marker of parietal cells.
Note that not all cells within the gastric gland are positive for epsin 3, as
seen by DAPI staining of nuclei. (Scale bar, 10 μm.)
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Fig. 3. Epsin 3 colocalizes with clathrin at apical canaliculi of parietal cells in
both resting (cimetidine) and stimulated (histamine) WT stomachs. Immu-
noﬂuorescence of semithin sections. (A) H/K ATPase is localized outside the
proﬁles of apical canaliculi (as deﬁned by ezrin immunoreactivity) in a rest-
ing cell, but is present at the canaliculi in a stimulated cell. A white asterisk
indicates the position of the nucleus. (B) Epsin 3 has a highly punctate lo-
calization at the cytoplasmic surface of canaliculi in both conditions. (C)
Epsin 3 spots overlap with a subset of clathrin spots (Insets show regions
enclosed by rectangles at higher magniﬁcation). The green ﬂuorescence
observed in some ﬁelds (black asterisks) is because of nonspeciﬁc ﬂuores-
cence generated by secondary antibodies. (Scale bars, 10 μm.)
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canaliculi, semithin sections of the stomach body were stained
by immunoﬂuorescence for epsin 3, the H/K ATPase, and ezrin.
Ezrin, a component of the membrane-associated cytoskeleton
(16), is highly concentrated at canaliculi and outlines their proﬁles.
Before ﬁxation by perfusion, mice were either injected with his-
tamine, to induce massive exocytosis of H/K ATPase-containing
membranes, or with the histamine H2-receptor antagonist cimet-
idine, to counteract endogenous histamine stimulation and thus
to observe parietal cells in their resting state.
As expected, the H/K ATPase was localized in the cytoplasm
outside the canalicular proﬁles, as deﬁned by the ezrin signal, in
cimetidine-treated samples, but strongly colocalized with ezrin
on the dilated canaliculi in histamine-treated samples (Fig. 3A).
These changes reﬂect a redistribution of H/K ATPase from the
tubulovesicles to the apical surface. Epsin 3 had a strongly
punctate localization that was juxtaposed to the ezrin signal in
both conditions, but colocalized with the H/K ATPase only in
stimulated samples, revealing a localization next to the apical
canaliculi (Fig. 3B). Further double-immunoﬂuorescence experi-
ments showed that all epsin 3 dots colocalized in both cimetidine-
and histamine-treated samples with a subset of clathrin immuno-
reactive dots, indicating a localization of epsin 3 at endocytic
clathrin-coated pits (Fig. 3C). However, clathrin immunoreactive
dots were not restricted to canaliculi, consistent with the well-
established additional presence of clathrin in the Golgi complex
and on endosomes (1, 17).
These results were complemented by electron microscopic ob-
servation of immunogold-labeled ultrathin frozen sections. H/K
ATPase immunoreactivity was primarily localized on the apical
microvilli in histamine-treated samples and on internal tubulove-
sicles in cimetidine-treated samples (Fig. 4). In adjacent sections
of the same samples, the great majority of anti-epsin 3 immuno-
gold was localized on pits (40% of the particles) and nearby
vesicles (30% of the particles) with a dense coat at the base of
apical microvilli in both histamine- and cimetidine-treated stom-
achs (Fig. 4 and Fig. S1). A similar distribution was observed for
anticlathrin immunogold used as a positive control (Fig. 4).
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Fig. 4. Electron microscopy localization of epsin 3 at coated pits and vesicles
at the base of apical canaliculi. Immunogold labeling of ultrathin frozen
sections. H/K ATPase is localized, as expected, on intracellular tubulovesicles
(asterisks) in cimetidine-treated samples and on the surface of microvilli
(arrows) in histamine-treated cells. In both conditions, epsin 3 (polyclonal
antibodies) and clathrin are found at the surface of invaginations among
microvilli and on underlying coated vesicles. (Scale bars, 100 nm.)
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Fig. 5. The shuttling of H/K ATPase between tubulovesicles and the apical
canaliculi is not impaired in epsin 3 KO stomachs. Immunoﬂuorescence of
semithin sections. In samples from both WT and epsin 3 KO mice, H/K ATPase
is localized outside the ezrin-positive canaliculi in cimetidine-treated samples
and relocates to the canaliculi after histamine treatment. (Scale bar, 10 μm.)
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Fig. 6. Colocalization of epsin 1 and 3 in parietal cells. (A) Double immu-
noﬂuorescence. (Scale bar, 10 μm.) (B) Colocalization of epsin 1 (5-nm gold)
and epsin 3 (10-nm gold) on coated vesicles as assessed by immunogold la-
beling of ultrathin frozen stomach sections. (Scale bar, 100 nm.)
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Epsin 3 Does Not Play an Essential Role in Gastric Parietal Cells. The
restricted pattern of epsin 3 expression suggested the possibility
that epsin 3 could play a unique and essential role in these cells.
To test this hypothesis, an epsin 3 KO mouse was generated (Fig.
S2). Epsin 3 KO mice were viable with no obvious develop-
mental, behavioral, or breeding defects. No abnormality was
detected by visual inspection of the skin, in spite of the reported
expression of epsin 3 in immature keratinocytes (12). The mice
stomachs were normal at histological examination (including
electron microscopic analysis) and their lumen had a low pH.
Furthermore, as in WT stomachs, H/K ATPase immunoreac-
tivity colocalized with ezrin in histamine-treated stomachs, but
outside the ezrin-positive canalicular proﬁles in cimetidine-
treated cells, indicating lack of a major defect in the shuttling of
membrane from tubulovesicles to the apical canaliculi (Fig. 5).
Most likely, epsin 1 and 2, which are also expressed in the stomach
(Fig. 1B), have overlapping function with epsin 3. Supporting this
possibility, double immunolabeling at the light and electron mi-
croscopic levels demonstrated colocalization of epsin 1 and 3 in
the stomach (epsin 2-speciﬁc antibodies suitable for immunolab-
eling were not available) (Fig. 6 A and B).
Selective Increase of EHD Proteins in Epsin 3 KO Stomachs. Often,
suppression of the expression of a protein results in adaptive
changes in the levels of other proteins, thus providing useful
insight into its function and about its functional partners. Based
on this rationale, the levels of several endocytic proteins was
analyzed in WT and epsin 3 KO stomachs (and WT and epsin 3
KO brains as controls) (Fig. 7A). Epsin 1 (but not epsin 2) levels
were slightly elevated in the KO stomach, most likely reﬂecting
a compensatory mechanism, but no change in epsin 1 levels was
observed in brain, where normal expression of epsin 3 is at the
limit of detectability. Clathrin, the clathrin adaptor AP-2, and
dynamin were expressed at much lower levels in the stomach
than in the brain, but did not undergo any change. No change
was observed for the epsin interactor Eps15, or for the α or the β
subunit of H/K ATPase, a stomach-speciﬁc protein, consistent
with the lack of an obvious abnormality in its trafﬁc. Inter-
estingly, expression levels of Hip1R (18), EHD1, and EHD2
(19–21) were higher in the stomach than in the brain. Hip1R,
a protein that shares partial domain similarity with epsin (it
contains an N-terminal ENTH-like domain) and that links cla-
thrin coats to the actin cytoskeleton, was previously shown to be
highly concentrated at apical canaliculi of gastric parietal cells
and to be implicated in H/K ATPase endocytosis (18, 22). Fur-
thermore, recent studies in Dictyostelium have suggested a strong
functional partnership between epsin and Hip1R at the interface
between clathrin-mediated endocytosis and actin (23). EHD2
was one of the proteins identiﬁed in a proteomic screen for
proteins concentrated in tubulovesicles (24). More importantly,
expression level of EHD1 and EHD2 were higher in epsin 3 KO
stomach than in WT (Fig. 7 A and B).
The increased levels of EHD proteins are of signiﬁcant in-
terest for several reasons. First, EHD proteins play a role in
recycling from the endosome to the plasma membrane (20, 21,
25), and thus may be implicated in membrane shuttling from
tubulovesicles to the plasma membrane of canaliculi. Second,
puriﬁed EHD proteins can deform lipid bilayers both in vitro
(19) and in vivo (26, 27) to generate EHD-coated tubules that
are in the same size range as tubulovesicles of gastric parietal
cells (27, 28). Third, they contain an EH domain homologous to
the EH domain of the epsin interactor Eps15 (i.e., a domain
predicting a potential interaction with the NPF motifs present in
the C-terminal region of the epsins) (25, 29, 30).
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Fig. 7. Western blots showing levels of expression of several endocytic
proteins in brain and stomach of WT and epsin 3 KO mice. (A) EHD1 and
EHD2 immunoreactive bands are selectively increased in the epsin 3 KO.
Note also a slight increase in the epsin 1 band selectively in the KO stomach.
(B) The increased levels of the EHD1 and EHD2 immunoreactive bands in the
KO stomachs were replicated in mice of two independent litters. GAPDH was
used as a loading control.
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Fig. 8. EHD1 and EHD2 interact with epsin. (A) Anti-epsin 1 and 3 Western
blots of material afﬁnity puriﬁed by GST or GST fusions of the EH domains of
Eps15 and of EHD1 or EHD2. The starting lysate and the pellets obtained by
incubating each fusion protein with and without lysate (lys) are shown. (B)
Fluorescence images of COS-7 cells cotransfected with HA-tagged epsin 3
and GFP-EHD proteins. The lower panels shows the boxed area of middle
panels at higher magniﬁcation. Arrows indicate some structures positive for
both epsin 3 and EHD proteins. (Scale bars, 10 μm.)
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A potential interaction of epsin with EHD1 and EHD2 was
directly tested in GST pull-downs from stomach extracts using the
EH domains of EHD1 and EHD2 (and of Eps15 as a control) as
bait (Fig. 8A). Both epsin 1 and 3 were speciﬁcally afﬁnity-puriﬁed
by the EH domains of all three proteins. Furthermore, EHD1
and EHD2 partially colocalized with HA-tagged epsin 3, both on
punctate structures and tubules, when co-overexpressed in COS-7
cells (Fig. 8B). These ﬁndings suggest a functional relation be-
tween the epsins and the EHD proteins.
Concluding Remarks. Collectively, our results demonstrate a se-
lective high-level expression of epsin 3 in gastric parietal cells
and suggest a role of epsin in the specialized membrane recycling
system of these cells. More speciﬁcally, they point to a role of
epsin 3 in clathrin-mediated endocytosis at their apical canal-
iculi. They further suggest a functional link of epsin to the EHD
proteins, whose properties makes them likely players in H/K
ATPase recycling via tubular membrane intermediates. The in-
tense exo-endocytic trafﬁc in gastric parietal cells is expected to
require cyclic conformational changes of membrane proteins. A
special property of epsin, among the clathrin adaptors, is to bind
ubiquitin. Thus, it will be of interest to determine whether func-
tions of epsin 3 in gastric parietal cells include a role in a quality-
control system aimed at removing misfolded and ubiquitinated
proteins, similar to what has been recently proposed in another
system (31).
Finally, beyond its cell biological signiﬁcance, selective ex-
pression of epsin 3 in specialized, highly differentiated cells of
the stomach may have implications for the classiﬁcation and
staging of gastric cancers. In preliminary results, we have found
that the majority of gastric cancers express epsin 3 at high levels,
but that the expression of this protein is on average lower in
metastasis derived from the same tumor (Fig. S3 A and B).
Furthermore, on average, epsin 3 mRNA is expressed at lower
levels in advanced gastric cancer than in early gastric cancer (Fig.
S3C). Thus, analysis of epsin 3 expression in gastric cancer may
be of diagnostic value.
Materials and Methods
Epsin 3 Gene Targeting. An epsin 3 conditional KO targeting vector was
custom made by Gene Dynamics: all of the nine coding exons (≈8 kb) of the
espin 3 gene (EPN3) were bracketed by two loxP sites, and an FRT site-
ﬂanked neomycin cassette to allow positive selection of ES cells was inserted
after the last coding exon (Fig. S2). The vector was electroporated in Hybrid
C57BL/6J-129S1/Sv mouse embryonic stem cells (Yale Cancer Center Animal
Genomics Shared Resource); surviving and correctly recombined clones were
identiﬁed by Southern blotting and injected into blastocysts of C57BL/6J
mice. Resulting chimeric mice were mated to a Cre deleter mouse strain (32)
to obtain an epsin 3 KO mouse.
Antibodies. Epsin 3-speciﬁc mouse monoclonal and rabbit polyclonal anti-
bodies were raised against the human epsin 3 sequence KQNGTKEP-
DALDLGILGEAL and the mouse epsin 3 sequence KQNGMKEPEALDLGV-
LGEAL, respectively (12). Sources of other antibodies are listed in the SI
Materials and Methods.
Microscopy. Mice were starved overnight and injected intraperitoneally with
cimetidine (120 mg/kg) or histamine (20 mg/kg) 30 min before perfusion
ﬁxation with 4% formaldehyde in sodium phosphate buffer, pH 7.2. Im-
munoﬂuorescence staining of thick (10 μm) and semithin (0.5 μm) frozen
stomach sections and immunogold labeling of ultrathin frozen sections
for electron microscopic analysis were carried out by standard procedures
(SI Materials and Methods). Animal work was approved by the Yale Uni-
versity Yale Animal Care and Use Committee (YACUC). For the analysis of
transfected ﬂuorescent proteins, COS-7 cells were transfected using Lip-
ofectamine 2000, ﬁxed in 4% formaldehyde, and observed using a spinning
disk confocal microscope, as described (33). The GFP-EHD1 and GFP-EHD2
plasmids were from our laboratory and a kind gift from H. McMahon
(Laboratory of Molecular Biology, Cambridge, United Kingdom), re-
spectively.
Biochemical Analyses. SDS/PAGE and Western blotting were carried out by
standard methods. GST pull-downs from stomach lysates were performed
essentially as described (34) using GST fusions of the EH domain containing
regions of human Eps15 (3), and of mouse EHD1 (aa 439–535) and mouse
EHD2 (aa 444–544) as bait.
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